An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
New study reveals poor outcomes for adults with congenital heart disease who develop heart failure
Poor HF outcomes found among adults with congenital heart disease
Cancer therapy and the heart: new resource now available to reliably measure strain
New resource for MDs to measure cardiac strain in cancer patients
Advanced imaging technique spots heart failure long before it sets in
Advanced imaging technique spots heart failure long before it sets in
Introducing TRANSFORM HF: digital innovation for heart failure care
TRANSFORM HF: digital innovation for heart failure care
New study explores how Apple Watch can help identify worsening heart failure early
Studying how Apple Watch can keep HF patients safe
Remarkable family history leads to chance to save lives
Remarkable family history leads to chance to save lives
Newer image method found to improve detection of chemotherapy-caused heart damage
Measuring strain key to detecting CV damage by chemotherapy
Common drug may protect hearts from damage caused by breast cancer chemotherapy
Statins found to help protect hearts of breast cancer patients
Behind the Breakthrough with Dr. Mansoor Husain
On a new diabetes drug that reduces the risk of heart failure
Ted Rogers Centre partners with Apple to test remote monitoring through smartwatch
“It’s a tremendous opportunity”